Acute thrombosis of a prosthetic mitral valve in pregnancy in spite of adjusted-dose low-molecular-weight heparin and aspirin

Journal of Heart Valve Disease

Volumn 17, Issue 1, 2008, Pages 133-134

  Curtis, Stephanie L ^a   Trinder, Johanna ^b   Stuart, A Graham ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b ST MICHAEL'S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART DISEASE; HEART VALVE REPLACEMENT; HUMAN; MALE; METHODOLOGY; MITRAL VALVE REGURGITATION; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PROSTHESIS FAILURE; REOPERATION; THROMBOSIS;

ADULT; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEART DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INFANT, NEWBORN; MALE; MITRAL VALVE INSUFFICIENCY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSTHESIS FAILURE; REOPERATION; THROMBOSIS;

EID: 43749103141     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (2)

1. Bates SM, Greer IA, Hirsh J, Ginsberg JS. Use of antithrombotic agents during pregnancy: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:627S-644S
2. Seshadri N, Goldhaber SZ, Elkayam U, et al. The clinical challenge of bridging anticoagulation with low-molecular-weight heparin in patients with mechanical prosthetic heart valves: An evidence-based comparative review focusing on anticoagulation options in pregnant and nonpregnant patients. Am Heart J 2005;150:27-34